Guardant in the News
Discussing the Pivotal Role Biomarker Testing Plays in Treatment of Lung Cancer Patients
Worldwide, lung cancer is the leading cause of cancer death,1 and in the U.S., more than 235,000 people will be diagnosed with lung cancer this year.2 Non-small cell lung cancer (NSCLC) is a devastating disease that accounts for 84% of all lung cancer diagnoses.2
Catching cancer extremely early
Better, faster, and earlier: Cancer screening has come of age, with many methods capable of testing multiple cancers in one sample.
We Must Implement Covid Relief Because Cancer Doesn’t Wait
Two weeks ago, I was proud to join more than 150 business leaders in signing a letter urging Congress to swiftly adopt a COVID-19 stimulus and relief plan. Today, I am thrilled that the American Rescue Plan has been signed into law by President Joe Biden. This relief package is a significant and necessary step in the fight against COVID that will invigorate the public health response to the crisis and support desperately needed vaccination efforts.
Helmy Eltoukhy’s Big Idea That Might Change The World
Scaling applies to people, not just companies — one has to keep learning new skills, on and off the job, to be able to continue adding value to hyper-scaling companies. Learning to hire, manage, lead, write, present more effectively are all necessary growth curves that young founders must dedicate time towards.